in this issue

The Pistoia Alliance has launched the User Experience for Life Sciences toolkit, designed to help pharma and biotech companies improve the user-friendliness of their software. We find out how poorly designed software can impact R&D, and how the toolkit could help.

We also consider the problem of unapproved and unregulated antibiotics being manufactured in India, investigate whether self-imposed price caps by some big pharma companies will be enough to keep drugs affordable, and find out more about Elsevier’s plans to create a new taxonomy for traditional Chinese medicine.

Finally, we take a look inside Canada’s Centre for Drug Research and Development as it works to solve unmet medical needs using innovative technologies, and unveil the six winning packaging systems at Pharmapack Europe 2018, which range from a motor-driven disposable auto-injector to an all-in-one contactless multi-dose delivery cap.

Katie Woodward, editor

Go to article: Home | Unlocking the potential of Chinese medicineGo to article: In This IssueGo to article: BrooksGo to article: ContentsGo to article: NewsGo to article: Fisher Clinical Services Company InsightGo to article: Fisher Clinical ServicesGo to article: Could focusing on the user experience reinvent drug R&D software?Go to article: EcocoolGo to article: How India’s use of unapproved antibiotics could undermine global healthGo to article: Pharma Support Services LtdGo to article: Pharma Support Services Ltd Company InsightGo to article: US drug pricing: could the industry regulate itself?Go to article: Gerresheimer AG Go to article: Unlocking the potential of Chinese medicineGo to article: Pfanstiehl, IncGo to article: Scandinavian Health LtdGo to article: Inside Canada’s centre for drug research and developmentGo to article: Scandinavian Health Ltd Company InsightGo to article: Award-winning pharma packagingGo to article: MalvernGo to article: Dividella AGGo to article: EventsGo to article: Event: CPhI ChinaGo to article: Next IssueGo to article: LaudaGo to article: DJAGo to article: ILC Dover IncGo to article: TemptimeGo to article: HaselmeierGo to article: Haselmeier AdvertorialGo to article: Syne Qua Non LtdGo to article: Gerteis